Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.
Press releases published on July 7, 2025
Innovating CAR Engineering: Creative Biolabs' Customized Solutions for Targeted Cell Therapy Innovation
EIN Presswire
·
July 7, 2025
Creative Biolabs has a professional platform that provides customized CAR construction and design, meeting diverse needs of CAR-T cell therapy research. SHIRLEY, NY, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- As worldwide demands for next- …
leagend Details Technical Features of leagend BT1000 Battery Tester with Bluetooth Functionality
EIN Presswire
·
July 7, 2025
leagend BT1000 is a 12 V battery and electrical system tester featuring built-in Bluetooth connectivity. NEW YORK, NY, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- Effective battery diagnostics have become increasingly reliant on remote monitoring …
PONY AI Inc. and Dubai RTA Co-Reveal Robotaxi Introduction
GlobeNewswire
·
July 7, 2025
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- Pony AI Inc. (“Pony.ai” or the “Company”) (Nasdaq: PONY), a global leader in achieving large-scale commercialization of autonomous mobility, and Dubai's Roads and Transport Authority (RTA) recently held a …
First patient dosed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy
GlobeNewswire
·
July 7, 2025
PARIS, July 07, 2025 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, is pleased to announce that the first patient has been …
Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe
GlobeNewswire
·
July 7, 2025
Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe A new report reveals that biosolutions could generate EUR 133 billion in economic gains and create over 600,000 jobs across all of Europe by 2035. But …
Eleva administers first dose of its Factor H biological treatment in C3-Glomerulopathy to healthy volunteers
GlobeNewswire
·
July 7, 2025
First-in-human administration of CPV-104 marks a major step in drug development for the company’s lead compound (Factor H) and in bringing a new medication to patients Freiburg im Breisgau, Germany, July 7, 2025 – Eleva, a pioneer in discovering and …
Ellomay and Statkraft Sign Long-Term Power Purchase Agreements for Three Operating Italian Solar Plants
GlobeNewswire
·
July 7, 2025
Tel-Aviv, Israel / Milan, Italy, July 07, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power …
Abinopharm, Inc. and EGT Synbio Announce Successful Human Clinical Trials on Oral L-Ergothioneine (Dr.Ergo®) for Skin Health
GlobeNewswire
·
July 7, 2025
SHELTON, Conn., July 06, 2025 (GLOBE NEWSWIRE) -- Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to announce that its partner, EGT Synbio, headquartered in Shanghai, China, has …
Ripple is applying for a national bank charter, LET Mining creates more value for XRP holders
GlobeNewswire
·
July 7, 2025
New York City, NY, July 06, 2025 (GLOBE NEWSWIRE) -- Ripple (XRP) has ended its battle with the U.S. Securities and Exchange Commission (SEC) and is getting rid of the supervision of the U.S. Securities and Exchange Commission (SEC). Garlinghouse tweeted: …